All Stories

  1. The prognosis of patients hospitalized with a first episode of heart failure, validation of two scores: PREDICE and AHEAD
  2. High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children <5 years of age admitted to hospital with clinical severe pneumonia
  3. Adecuación de tromboprofilaxis en pacientes médicos hospitalizados en Andalucía. Estudio multicéntrico
  4. Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers
  5. AIDS-related Pneumocystis jirovecii genotypes in French Guiana
  6. Serum and bal beta-d-glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients
  7. High prevalence of Pneumocystis jirovecii colonization among HIV-positive patients in southern Brazil
  8. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load
  9. Pneumocystisand Pneumocystosis: first meeting of experts from Latin-American and Portuguese-speaking countries – a mini-review
  10. Genetic diversity of Pneumocystis jirovecii in colonized Cuban infants and toddlers
  11. Attitudes and Perceptions about Clinical Guidelines: A Qualitative Study with Spanish Physicians
  12. Use of clinical practice guidelines and factors related to their uptake: a survey of health professionals in Spain
  13. Prevalence and Genotype Distribution of Pneumocystis jirovecii in Cuban Infants and Toddlers with Whooping Cough
  14. Pneumocystis jiroveciipneumonia in Latin America. A public health problem?
  15. The 12th International Workshops on Opportunistic Protists (IWOP-12)
  16. High prevalence ofPneumocystis jiroveciicolonization in Brazilian cystic fibrosis patients
  17. Low genetic diversity ofPneumocystis jiroveciiamong Cuban population based on two-locus mitochondrial typing
  18. Highly pathogenic avian influenza virus H5N1 controls type I IFN induction in chicken macrophage HD-11 cells: a polygenic trait that involves NS1 and the polymerase complex
  19. Pneumocystis jirovecii colonization in patients treated with infliximab
  20. Prevalence of HTLV-1/2 Infections in Spain: A Cross-Sectional Hospital-Based Survey
  21. Metagenomic analysis of bronchoalveolar lavage samples from patients with idiopathic interstitial pneumonia and its antagonic relation with Pneumocystis jirovecii colonization
  22. Pneumocystisinfection in humans: diagnosis and treatment
  23. Pneumocystisinfection: unraveling the colonization-to-disease shift
  24. PneumocystisInfection: Seeing beyond the Tip of the Iceberg
  25. El ser humano como reservorio de Pneumocystis
  26. Epidemiology of Pneumocystis infection in Human
  27. Geographical variation in serological responses to recombinant Pneumocystis jirovecii major surface glycoprotein antigens
  28. Seroprevalence of HTLV-1/2 Infection among Native and Immigrant Pregnant Women in Spain
  29. Prevalence of dihydropteroate synthase mutations in Spanish patients with HIV-associated Pneumocystis pneumonia
  30. HypotheticalPneumocystis jiroveciiTransmission from Immunocompetent Carriers to Infant
  31. Vertical Transmission ofPneumocystis jiroveciiin Humans
  32. Prevention of Pneumocystis pneumonia in patients with inflammatory bowel disease based on the detection of Pneumocystis colonization
  33. Profilaxis de la enfermedad tromboembólica venosa: ¿una asignatura pendiente?
  34. Pneumocystis jiroveciiTransmission from Immunocompetent Carriers to Infant
  35. Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain
  36. Antiphospholipid antibodies investigation in Pneumocystis jirovecii carriers
  37. Dynamic colonisation by different Pneumocystis jirovecii genotypes in cystic fibrosis patients
  38. Short Communication: Hospital-Based Surveillance for HTLV-1/2 Infections in Spain
  39. Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease Who Are Colonized with Pneumocystis jiroveci
  40. Infección por el virus de la inmunodeficiencia humana tipo 2 y virus linfotrópicos humanos tipos 1 y 2 en España
  41. Prevalencia de enfermedad arterial periférica estimada mediante el índice tobillo-brazo en pacientes con síndrome metabólico. Estudio MERITO I
  42. Comparison of Single and Touchdown PCR Protocols for Detecting Pneumocystis jirovecii DNA in Paraffin-Embedded Lung Tissue Samples
  43. Usefulness Of Oropharyngeal Washings For Identifying Pneumocystis jirovecii Carriers
  44. Occurrence of bacterial indicators and bacteriophages infecting enteric bacteria in groundwater in different geographical areas
  45. Pneumocystis jirovecii: un nuevo nombre para un viejo patógeno
  46. Polymorphisms inPneumocystis jiroveciiStrains in Spanish Children with Cystic Fibrosis
  47. Pneumocystis jirovecii colonisation in patients with interstitial lung disease
  48. Prevalence of colonisation and genotypic characterisation of Pneumocystis jirovecii among cystic fibrosis patients in Spain
  49. Work, career satisfaction, and the position of general internists in the south of Spain
  50. Risk of venous thromboembolic disease in women
  51. Efectividad de la implantación de una guía clínica sobre la angina inestable mediante una estrategia multifactorial. Ensayo clínico aleatorizado en grupos
  52. Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain
  53. Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain
  54. High seroprevalence of Pneumocystis infection in Spanish children
  55. Climatic factors and Pneumocystis jiroveci infection in southern Spain
  56. Epidemiology of Pneumocystis carinii pneumonia in southern Spain
  57. Pneumocystis jiroveci Genotypes in the Spanish Population
  58. Infecciones por VIH-2 y HTLV-I/II en España
  59. Association between human-Pneumocystis infection and small-cell lung carcinoma
  60. Cosmopolitan HTLV-Ia Subtype Among Spanish Native Patients
  61. Lymphocyte Response in Subjects with Chronic Pulmonary Disease Colonized by Pneumocystis jirovecii
  62. Seroprevalence of Pneumocystis Human Infection in Southern Spain
  63. Primary lymphoma of the central nervous system and HTLV-I infection
  64. Candesartan and acute liver injury
  65. Prevalence of HTLV infection in pregnant women in Spain
  66. Enoxaparin for the Prevention of Venous Thromboembolism
  67. Absence of Pneumocystis carinii Carriers among Patients with Cystic Fibrosis
  68. Evidence for a role of T-helper type 2 cytokines in the acquisition of human immunodeficiency virus syncytium-inducing phenotype
  69. Significance of indeterminate reactivity to human T-Cell lymphotropic virus in Western blot analysis of individuals at risk
  70. Presence of glomerular basement membrane (GBM) antibodies in HIV−patients with Pneumocystis carinii pneumonia
  71. Epidemiology of HIV-2 infection in Spain
  72. HTLV-I-Associated Illnesses in Spain
  73. Prevalence of infection by human T-cell leukemia virus types I and II in southern Spain
  74. Emergence and clinical relevance of mutations associated with zidovudine resistance in asymptomatic HIV-1 infected patients
  75. Avoiding false-negative results for HTLV-II using new serological assays
  76. CD4+ T-lymphocytopenia in the elderly
  77. Does Early Zidovudine Treatment Prevent The Emergence Of Syncytium-Inducing Human Immunodeficiency Virus?
  78. HTLV-I and HTLV-II Infections in Spain
  79. HTLV-I/II Infections in Spain
  80. Absence of HTLV-I and HTLV-II infection in prostitutes in the area of seville, Spain
  81. Predictive value of the presence of P24 antigen in persons with antibodies to human immunodeficiency virus in Spain